Application and Results of Different Chemotherapy Regimens in Primary Liver Malignancies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication
1975 • 188 citations
Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma
1982 • 182 citations
Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial
1978 • 159 citations
Primary liver cancer. An eastern cooperative oncology group trial
1984 • 120 citations
Induction of remission in hepatocellular carcinoma: A comparison of VP 16 with adriamycin
1983 • 109 citations
Principles of Cancer Treatment
2011 • 102 citations
Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma
1977 • 95 citations
Malignant hepatoma in the Bantu
1970 • 87 citations
Hepatomas: hormone receptors and therapy.
1982 • 86 citations
A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States
1977 • 84 citations
Principles of Cancer Treatment
1982 • 81 citations
Further experience in treating patients with hepatocellular carcinoma in Uganda
1980 • 79 citations
Liver cell cancer
1976 • 72 citations
Hepatomas: Hormone receptors and therapy
1982 • 69 citations
Adriamycin therapy in American patients with hepatocellular carcinoma.
1977 • 57 citations
Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects
1981 • 39 citations
Phase II study of oral VP-16-213 in hepatocellular carcinoma
1981 • 34 citations
Systemic and regional treatment of primary carcinoma of the liver
1977 • 32 citations
Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
1977 • 31 citations
Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
1981 • 30 citations
A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma
1980 • 30 citations
Therapeutic approaches to hepatoma
1975 • 23 citations
A phase II study of m-AMSA in patients with primary liver cancer
1981 • 18 citations
Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.
1982 • 18 citations
THE TREATMENT OF LIVER CELL CANCER
1976 • 11 citations
ALLOXAN AS A POSSIBLE THERAPEUTIC AGENT FOR PRIMARY CARCINOMA OF THE LIVER
1957 • 2 citations